Skip to content
S6972Senate2021-2022 SessionSame asA7817

Protect Transit Workers’ Lungs

Official title

“Relates to certain lung disabilities incurred by members of the New York city transit authority in certain cases”

Sponsor Andrew GounardesSD-22Affects Finance
Status
Vetoed
Impact
3/10
Low
Outcome
Vetoed

Bill progress

Vetoed

What's happening

This bill creates a presumption that lung diseases in New York City Transit Authority employees are work-related for disability or death benefits.

Why it matters

  1. Shifts Burden of Proof. By establishing a presumption that lung diseases in Transit Authority employees are work-related, the bill makes it significantly easier for affected workers (or their families) to receive disability or death benefits, as they no longer need to prove the disease was caused by their job if they had a clean physical when hired.

  2. Limits Employer/Self-Insurance Defenses. The bill does not provide a clear way for the Transit Authority or insurers to rebut the presumption with contrary evidence, which could mean almost automatic benefit eligibility for qualifying employees, potentially increasing the number and success rate of claims.

  3. Potentially Significant Financial Impact. While the number of eligible employees is currently small, each qualifying disability or death event could cost the Transit Authority (and, by extension, taxpayers or transit users) a substantial amount—estimated at $32,500 to $504,600 per event—raising concerns about future pension system costs if the eligible group expands.

  4. Precedent for Other Worker Categories. Creating a broad presumption for lung diseases may prompt similar legislative efforts for other public workers or for other types of occupational illnesses, influencing the landscape of public sector disability law and benefits.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Transit Authority and subsidiary members with lung disease

    The bill would presume that disabling or fatal lung disease was duty-related if an examination at entry into service or afterward showed no evidence of the condition.

  • Likely support

    Beneficiaries of covered members

    The presumption could support accidental death benefit claims when a qualifying member dies from lung disease.

  • New York City Employees’ Retirement System (NYCERS)

    The system would administer the presumption, which the fiscal note identifies as affecting eligible Tier 1 and Tier 2 Transit Authority members.

  • Transit Authority pension employers

    The fiscal note projects higher employer pension contributions when eligible members receive benefits under the bill.

Headline styles

Protect Transit Workers’ Lungs

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Andrew Gounardes

Senator · Senate District 22

Chair, Budget And Revenue

No co-sponsors yet.

History

  1. Vetoed memo.87
  2. Delivered to governor
  3. Returned to senate
  4. Passed assembly
  5. Ordered to third reading rules cal.629
  6. Substituted for A7817
  7. Referred to ways and means
  8. Delivered to assembly
  9. Passed senateVote 63–0
  10. Ordered to third reading cal.1412
  11. Committee discharged and committed to rules
  12. Referred to cities 1

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A7817Assembly

Lung Disease Presumption for Transit Workers

Assembly Floor Calendar · Sponsor Peter Abbate

Impact 3 · Low0% to pass

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

6972

2021-2022 Regular Sessions

IN SENATE

May 20, 2021

Introduced by Sen. GOUNARDES -- read twice and ordered printed, and when printed to be committed to the Committee on Cities 1

AN ACT to amend the administrative code of the city of New York, in relation to certain lung disabilities incurred by members of the New York city transit authority in certain cases

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The administrative code of the city of New York is amended by adding a new section 13-168.1 to read as follows:

§ 13-168.1 Transit authority members; presumption in certain diseases. Notwithstanding any provision of this chapter or of any general, special or local law to the contrary, and for the purposes of this chapter, any condition of impairment of health caused by diseases of the lung, resulting in total or partial disability or death to a member of the New York city transit authority, or a member of its subsidiary corporation, as defined in section twelve hundred three-a of the public authorities law, where such member successfully passed a physical examination on entry into such service or subsequent thereto, which examination failed to reveal any evidence of such condition, shall be presumptive evidence that it was incurred in the performance and discharge of duty.

§ 2. This act shall take effect immediately.

FISCAL NOTE.--Pursuant to Legislative Law, Section 50:

SUMMARY OF BILL: This proposed legislation would amend the Administra-

tive Code of the City of New York (ACCNY) to add a new Section 13-168.1

to provide a statutory presumption to Tier 1 and Tier 2 members of the

New York City Employees' Retirement System (NYCERS) who are Transit

Authority employees, and who become physically incapacitated for

performance of duty, or die, due to lung disease.

In determining whether qualifying lung disease was caused by employ-

ment for the Transit Authority, the diagnosis of lung disease, absent

evidence of such condition upon examination at hire, would be presump-

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD08575-02-1

S. 6972 2

tive evidence that such disability or death was incurred in the perform-

ance and discharge of duty entitling such member, or his or her benefi-

ciary, respectively, to an accident disability retirement or accidental

death benefit. The proposed legislation does not appear to provide a

mechanism for rebutting such presumption with competent evidence to the

contrary.

Effective Date: Upon enactment.

FINANCIAL IMPACT - OVERVIEW: There is no data available to estimate

the number of members who might develop and become disabled by or die

from lung disease, and potentially benefit from this proposed legis-

lation. Therefore, the estimated financial impact has been calculated

on a per event basis equal to the increase in the Present Value of

Future Benefits (PVFB) for an average affected member who is diagnosed

with lung disease as the result of the enactment of the proposed legis-

lation and who would benefit from the proposed legislation.

In determining the increase in the PVFB, it has been assumed that 100%

of the members who would retire with lung disease would have continued

working and eventually retired for service if the proposed legislation

were not passed. The increase in PVFB does not include any cost for

additional death benefits since the ordinary death benefit for these

members is more valuable than the accidental death benefit in most

cases.

With respect to an individual member, the additional cost of this

proposed legislation varies greatly.

FINANCIAL IMPACT - PRESENT VALUES: Based on the census data and the

actuarial assumptions and methods described herein, the enactment of

this proposed legislation would increase the PVFB and decrease the Pres-

ent Value of member contributions, for a net result of an increase in

the Present Value of future employer contributions ranging from $32,500

to $504,600 if one of the eight members who could benefit from the

proposed legislation develops a qualifying lung disease. The average

increase in the Present Value of future employer contributions for the

eight members who could benefit from the proposed legislation is approx-

imately $207,000.

FINANCIAL IMPACT - ANNUAL EMPLOYER CONTRIBUTIONS: Enactment of this

proposed legislation would increase employer contributions, where such

amount would depend on the number of members affected as well as other

characteristics including the age, years of service, and salary history

of each member.

As there is no data currently available to estimate the number of

members who might be diagnosed with disabling lung disease, the finan-

cial impact would be recognized at the time of event. Consequently,

changes in employer contributions have been estimated assuming that the

increase in the Present Value of future employer contributions will be

financed over the same time period used for actuarial losses in accord-

ance with Section 13-638.2(k-2) of the ACCNY. Using this approach, the

additional Present Value of future employer contributions would be amor-

tized over a closed 15-year period (14 payments under the One-Year Lag

Methodology) using level dollar payments.

Based on the Actuary's actuarial assumptions and methods in effect as

of June 30, 2019, the enactment of this proposed legislation is esti-

mated to increase annual employer contributions by an amount ranging

from $3,800 to $59,700 if one of the eight members who could benefit

from the proposed legislation develops a qualifying lung disease. The

average increase in annual employer contributions for the eight members

who could benefit from the proposed legislation is approximately

S. 6972 3

$24,500. With respect to the timing, increases in employer contributions

would depend upon when members would retire due to lung disease but,

generally, increased employer contributions will first occur the second

fiscal year following approval of the accident disability or accidental

death benefit.

CENSUS DATA: The estimates presented herein are based on the census

data used in the Preliminary June 30, 2020 (Lag) actuarial valuation of

NYCERS to determine the Preliminary Fiscal Year 2022 employer contrib-

utions.

There are eight active Tier 1 and Tier 2 Transit Authority employees

who participate in NYCERS as of June 30, 2020 who could potentially

benefit from the proposed legislation. These eight active Tier 1 and

Tier 2 Transit Authority members had an average age of approximately

72.3 years, average service of approximately 29.8 years, and an average

salary of approximately $99,200. This group consisted of three Tier 1

members, and five Tier 2 members.

ACTUARIAL ASSUMPTIONS AND METHODS: The changes in the PVFB and annual

employer contributions presented herein have been calculated based on

the actuarial assumptions and methods in effect for the June 30, 2019

(Lag) actuarial valuations used to determine the Preliminary Fiscal Year

2021 employer contributions of NYCERS.

The Actuary is proposing a set of changes for use beginning with the

June 30, 2019 (Lag) actuarial valuations of NYCERS to determine the

Final Fiscal Year 2021 Employer Contributions (2021 A&M). If the 2021

A&M is enacted, it is estimated that the Present Value of Employer

Contributions and annual employer contributions will be approximately 2%

smaller than the results shown above.

RISK AND UNCERTAINTY: The costs presented in this Fiscal Note depend

highly on the realization of the actuarial assumptions used, as well as

certain demographic characteristics of NYCERS and other exogenous

factors such as investment, contribution, and other risks. If actual

experience deviates from actuarial assumptions, the actual costs could

differ from those presented herein. Costs are also dependent on the

actuarial methods used, and therefore different actuarial methods could

produce different results. Quantifying these risks is beyond the scope

of this Fiscal Note.

Not measured in this Fiscal Note are the following:

* The initial, additional administrative costs of NYCERS and other

New York City agencies to implement the proposed legislation.

* The impact of this proposed legislation on Other Postemployment

Benefit (OPEB) costs.

STATEMENT OF ACTUARIAL OPINION: I, Sherry S. Chan, am the Chief Actu-

ary for, and independent of, the New York City Retirement Systems and

Pension Funds. I am a Fellow of the Society of Actuaries, an Enrolled

Actuary under the Employee Retirement Income and Security Act of 1974, a

Member of the American Academy of Actuaries, and a Fellow of the Confer-

ence of Consulting Actuaries. I meet the Qualification Standards of the

American Academy of Actuaries to render the actuarial opinion contained

herein. To the best of my knowledge, the results contained herein have

been prepared in accordance with generally accepted actuarial principles

and procedures and with the Actuarial Standards of Practice issued by

the Actuarial Standards Board.

FISCAL NOTE IDENTIFICATION: This Fiscal Note 2021-26 dated May 19,

2021 was prepared by the Chief Actuary for the New York City Employees'

Retirement System. This estimate is intended for use only during the

2021 Legislative Session.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the administrative code of the city of New York, in relation to certain lung disabilities incurred by members of the New York city transit authority in certain cases

Purpose or general idea of bill

The bill creates a statutory presumption of lung disease that results in disability or death being a result of the performance of duty for trans- it workers in New York city, as long as the disease was found to be not present during the physical examination of the member upon entrance to the occupation.

Summary of provisions

Section one of the bill adds a new section 13.168.1 to the Administra- tive Code of the City of New York to create a presumption of lung disease related to the performance of duty of transit workers in NYC. The section qualifies the presumption as existing only when an occupa- tional entrance physical exam did not detect any signs of the lung disease.

Section two sets the effective date.

Justification

New York city transit workers perform physically exhausting duties in settings where they are exposed to various environmental conditions that a large majority of laborers do not have to operate in.

In these settings, transit workers are frequently exposed to a variety of biological conditions and pollutants that are found in subway tunnels, underground work sites and on mass polluted roadways.

In fact, in 2005, a scientific research study was funded by a grant from the New York State Legislature through the New York State Department of Health to the Transport Workers Union Local 100. The study, titled "Health Impact of Urban Mass Transportation Work in New York City," was conducted by doctors and researchers from New York Committee for Occupa- tional Safety and Health, The City University of New York and Mount Sinai School of Medicine. The study concluded that transit workers develop important, common diseases and injuries to which their work is likely to be a causal or contributing factor. Such injuries and diseases have been identified by a substantial body of scientific research, including epidemiologic and mechanism-based studies. The major health outcomes of concern are cardiovascular diseases, which include hyperten- sion, heart disease, and stroke; lung and bladder cancer and possibly other cancers; emphysema and asthma.

This bill will provide a necessary presumption for transit workers seek- ing benefits or making claims of labor-induced medical complications of lung disease.

Prior legislative history

2020: S6137A - Referred to Civil Service & Pensions

2019: S6137A - Referred to Civil Service & Pensions

Fiscal implications

See bill

Effective date

Immediately

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.